Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse
- PMID: 7522160
- DOI: 10.1002/eji.1830240926
Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse
Abstract
Immunomodulatory treatment paradigms have been applied to animal models of T cell-mediated autoimmune diseases in an attempt to develop an immunospecific and non-toxic form of therapy which can be applied to humans. These treatment paradigms are often directed to T cells with a restricted T cell receptor repertoire or that react with dominant peptide determinants. Experimental data, however, suggests that even if the initial T cell response is restricted to a specific self-protein in the target organ, spreading autoimmunity may develop with broadening of T cell autoreactivity to additional epitopes of the same autoantigen or to different autoantigens in the target organ. Thus, multiple autoantigens may become targets of the autoimmune response. This makes immunotherapeutic strategies based on suppressing responses to restricted proteins or clones of cells problematic. We have previously shown that suppression of experimental autoimmune encephalomyelitis (EAE) in the Lewis rat by oral myelin basic protein (MBP) is mediated by the release of transforming growth factor-beta after triggering by the oral tolerogen. Here, we report that in the SJL model of EAE oral administration of an autoantigen from the target tissue suppresses disease independent of whether it is or is not the inciting antigen. Thus, orally administered MBP or MBP peptides suppress proteolipid protein (PLP)-induced EAE, whereas intravenously administered MBP does not. Both oral and intravenous PLP, however, suppressed PLP disease. These findings have important implications for the use of oral tolerance as a therapeutic approach for the treatment of T cell-mediated inflammatory autoimmune diseases in man in which the inciting autoantigen is unknown or in which there is autoreactivity to multiple autoantigens in the target tissue.
Similar articles
-
Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.J Immunol. 1993 Dec 15;151(12):7307-15. J Immunol. 1993. PMID: 7505026
-
Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.J Immunol. 1992 May 1;148(9):2748-55. J Immunol. 1992. PMID: 1374098
-
Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.J Clin Invest. 1996 Oct 1;98(7):1602-12. doi: 10.1172/JCI118954. J Clin Invest. 1996. PMID: 8833909 Free PMC article.
-
Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.Annu Rev Immunol. 1994;12:809-37. doi: 10.1146/annurev.iy.12.040194.004113. Annu Rev Immunol. 1994. PMID: 8011298 Review.
-
Maintenance of immunologic self-tolerance by nonimmunogenic forms of antigen.Clin Exp Immunol. 1976 Dec;26(3):597-600. Clin Exp Immunol. 1976. PMID: 64328 Free PMC article. Review.
Cited by
-
The role of dendritic cells in tissue-specific autoimmunity.J Immunol Res. 2014;2014:857143. doi: 10.1155/2014/857143. Epub 2014 Apr 30. J Immunol Res. 2014. PMID: 24877157 Free PMC article. Review.
-
Bystander immunotherapy as a strategy to control allergen-driven airway inflammation.Mucosal Immunol. 2015 Jul;8(4):841-51. doi: 10.1038/mi.2014.115. Epub 2014 Nov 26. Mucosal Immunol. 2015. PMID: 25425267 Free PMC article.
-
Oral tolerance with copolymer 1 for the treatment of multiple sclerosis.Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3333-5. doi: 10.1073/pnas.96.7.3333. Proc Natl Acad Sci U S A. 1999. PMID: 10097037 Free PMC article. Review. No abstract available.
-
Proinsulin: a unique autoantigen triggering autoimmune diabetes.J Clin Invest. 2006 Dec;116(12):3108-10. doi: 10.1172/JCI30760. J Clin Invest. 2006. PMID: 17143326 Free PMC article.
-
New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis.J Neurol. 1996 Apr;243(4 Suppl 1):S8-13. doi: 10.1007/BF00873696. J Neurol. 1996. PMID: 8965119 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous